SCHEMBL6163503

SCHEMBL6163503

CC1(C)CCc2c(c(-c3ccccc3)nn2CC(F)(F)F)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.40
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
POLQ O75417 2/20 0.34
BUB1 O43683 1/20 0.34
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
SRC P12931 1/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ALOX15 P16050 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
ADORA3 P0DMS8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164936 0.90 CDC7 (0.39) PTGS2BUB1ALDH1A1
SCHEMBL6167206 0.87 METAP2 (0.34) PTGS2POLQ
SCHEMBL6163459 0.85 HDAC9 (0.35) PTGS2KMT2APOLQALDH1A1
SCHEMBL6166715 0.85 KCNK3 (0.39) KMT2ATSHRHSD17B10CYP1A2CYP2C9
SCHEMBL6165976 0.82 ADORA1 (0.38) MEN1KMT2ASMN1; SMN2TSHRHSD17B10
SCHEMBL6165367 0.82 EEF2K (0.32) MEN1KMT2APOLQHSD17B10ALOX15
SCHEMBL6166778 0.82 TSHR (0.34) PTGS2POLQBUB1TSHRCYP1A2
SCHEMBL6165500 0.81 PTGS2 (0.38) PTGS2MEN1KMT2ASMN1; SMN2POLQ
SCHEMBL6167776 0.81 AURKA (0.31) PTGS2
SCHEMBL6164523 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 WO disclosed